Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Ischemic Heart Disease

Free Subscription 15.11.2021 3 Am J Cardiol 1 Am J Emerg Med 1 Blood 1 BMJ 1 Chest 1 Circ Cardiovasc Interv 1 Circ Cardiovasc Qual Outcomes 3 Circulation 1 Clin Cardiol 2 Eur Heart J 1 Hypertension 5 Int J Cardiol 2 J Clin Endocrinol Metab 1 J Clin Invest 1 J Mol Cell Cardiol 1 J Thorac Cardiovasc Surg 3 JAMA 4 Lancet 1 N Engl J Med 1 PLoS Med 9 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. KAWSARA A, El Shaer A, Khalouf A, Almakadma AH, et al
   Differences in Risk Profile, Management, and Outcomes of ST-Elevation Myocardial Infarction Between Asian Versus White Patients in Contemporary United States Practice.
   Am J Cardiol. 2021;160:132-133.
   PubMed        
   
   
2. ABUSNINA W, Alam M, Dahal K
   Meta-Analysis Comparing Outcomes of Invasive Versus Conservative Strategy in Octogenarians With Non-ST Segment Elevation Acute Myocardial Infarction.
   Am J Cardiol. 2021;160:130-132.
   PubMed        
   
   
3. WILLIAMS BA, Riangwiwat T, Voyce S, Blankenship JC, et al
   Burden and Predictors of Chest Pain-Related Health-Care Utilization Following Percutaneous Coronary Intervention.
   Am J Cardiol. 2021;160:31-39.
   PubMed         Abstract available
   
   

   
   Am J Emerg Med

4. CLODFELDER C, Cooper S, Edwards J, Kraemer J, et al
   Delayed care in myocardial infarction and ischemic stroke patients during the COVID-19 pandemic.
   Am J Emerg Med. 2021 Oct 25. pii: S0735-6757(21)00858.
   PubMed         Abstract available
   
   

   
   Blood

5. HERRMANN J, McCullough K, Habermann TM
   How I treat cardiovascular complications in patients with lymphoid malignancies.
   Blood. 2021 Nov 9. pii: 477914. doi: 10.1182/blood.2019003893.
   PubMed         Abstract available
   
   

   
   BMJ

6. SAUL H, Gursul D
   Even low doses of steroids increase the risk of cardiovascular disease in people with inflammatory diseases.
   BMJ. 2021;375:n2599.
   PubMed         Abstract available
   
   

   
   Chest

7. FENG W, Zhang Z, Liu Y, Li Z, et al
   Association of chronic respiratory symptoms with incident cardiovascular disease and all-cause mortality: findings from the Coronary Artery Risk Development in Young Adults Study.
   Chest. 2021 Nov 2. pii: S0012-3692(21)04255-0. doi: 10.1016/j.chest.2021.
   PubMed         Abstract available
   
   

   
   Circ Cardiovasc Interv

8. KONSTANTINOU K, Keeble TR, Davies JR, Gamma RA, et al
   Discordance Between Coronary Flow Reserve and the Index of Microcirculatory Resistance Post-Revascularization for ST-Segment-Elevation Myocardial Infarction.
   Circ Cardiovasc Interv. 2021 Nov 9:CIRCINTERVENTIONS121010529.
   PubMed        
   
   

   
   Circ Cardiovasc Qual Outcomes

9. SUKUL D, Seth M, Thompson MP, Keteyian SJ, et al
   Hospital and Operator Variation in Cardiac Rehabilitation Referral and Participation After Percutaneous Coronary Intervention: Insights From Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
   Circ Cardiovasc Qual Outcomes. 2021 Nov 9:CIRCOUTCOMES121008242.
   PubMed         Abstract available
   
   

   
   Circulation

10. ZAHA VG, Hayek SS, Alexander KM, Beckie TM, et al
    Future Perspectives of Cardiovascular Biomarker Utilization in Cancer Survivors: A Scientific Statement From the American Heart Association.
    Circulation. 2021 Nov 10:CIR0000000000001032. doi: 10.1161/CIR.0000000000001032.
    PubMed         Abstract available
    
    
11. 
    Correction to: Combined Associations of Changes in Noncombustible Nicotine or Tobacco Product and Combustible Cigarette Use Habits With Subsequent Short-Term Cardiovascular Disease Risk Among South Korean Men: A Nationwide Cohort Study.
    Circulation. 2021;144:e306.
    PubMed        
    
    
12. TONG DC, Bloom JE, Quinn S, Nasis A, et al
    Colchicine in Patients With Acute Coronary Syndrome: Two-Year Follow-Up of the Australian COPS Randomized Clinical Trial.
    Circulation. 2021;144:1584-1586.
    PubMed        
    
    

    
    Clin Cardiol

13. XING Z, Wang X, Pei J, Zhu Z, et al
    The association of interferon-alpha with development of collateral circulation after artery occlusion.
    Clin Cardiol. 2021;44:1621-1627.
    PubMed         Abstract available
    
    

    
    Eur Heart J

14. EGIDY ASSENZA G, Dimopoulos K, Budts W, Donti A, et al
    Management of acute cardiovascular complications in pregnancy.
    Eur Heart J. 2021;42:4224-4240.
    PubMed         Abstract available
    
    
15. HAN Y
    Long-term outcomes of new-generation coronary stents in China.
    Eur Heart J. 2021 Sep 18. pii: 6372216. doi: 10.1093.
    PubMed        
    
    

    
    Hypertension

16. LAKSHMAN R, Spiroski AM, McIver LB, Murphy MP, et al
    Noninvasive Biomarkers for Cardiovascular Dysfunction Programmed in Male Offspring of Adverse Pregnancy.
    Hypertension. 2021;78:1818-1828.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

17. BERNTORP K, Persson J, Koul SM, Patel MR, et al
    Instantaneous wave-free ratio compared with fractional flow reserve in PCI: A cost-minimization analysis.
    Int J Cardiol. 2021;344:54-59.
    PubMed         Abstract available
    
    
18. TSUJITA K
    Realistic detection of natural history of early coronary atherosclerosis: Best part of computed tomography-derived fractional flow reserve?
    Int J Cardiol. 2021;344:34-35.
    PubMed        
    
    
19. SOFI F, Dinu M, Reboldi G, Stracci F, et al
    Worldwide differences of hospitalization for ST-segment elevation myocardial infarction during COVID-19: A systematic review and meta-analysis.
    Int J Cardiol. 2021 Nov 2. pii: S0167-5273(21)01765.
    PubMed         Abstract available
    
    
20. BANG C, Lauridsen KG, Andersen CF, Lofgren B, et al
    Reply to the Letter to the Editor: "Is single troponin measurement truly safe enough to rule out myocardial infarction in early presenters?"
    Int J Cardiol. 2021 Nov 2. pii: S0167-5273(21)01761.
    PubMed        
    
    
21. RIJLAARSDAM-HERMSEN D, van Domburg RT, Deckers JW, Kuijpers D, et al
    Comparison of guidelines for diagnosing suspected stable angina and the additional value of the calcium score.
    Int J Cardiol. 2021;344:1-7.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

22. ZUO Y, Han X, Tian X, Chen S, et al
    Association of Impaired Fasting Glucose with Cardiovascular Disease in the Absence of Risk Factor.
    J Clin Endocrinol Metab. 2021 Nov 8. pii: 6423498. doi: 10.1210.
    PubMed         Abstract available
    
    
23. SAATMANN N, Zaharia OP, Strassburger K, Pesta DH, et al
    Physical fitness and cardiovascular risk factors in the novel diabetes subgroups.
    J Clin Endocrinol Metab. 2021 Nov 8. pii: 6423502. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Clin Invest

24. JIANG K, Tu Z, Chen K, Xu Y, et al
    Gasdermin D inhibition confers antineutrophil mediated cardioprotection in acute myocardial infarction.
    J Clin Invest. 2021 Nov 9. pii: 151268. doi: 10.1172/JCI151268.
    PubMed         Abstract available
    
    

    
    J Mol Cell Cardiol

25. CAGGIANO LR, Holmes JW, Witzenburg CM
    Individual variability in animal-specific hemodynamic compensation following myocardial infarction.
    J Mol Cell Cardiol. 2021 Oct 28. pii: S0022-2828(21)00207.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

26. ABOULGHEIT A, Karbasiafshar C, Sabra M, Zhang Z, et al
    Extracellular vesicles improve diastolic function and substructure in normal and high-fat diet models of chronic myocardial ischemia.
    J Thorac Cardiovasc Surg. 2021 Oct 13. pii: S0022-5223(21)01420.
    PubMed         Abstract available
    
    

    
    JAMA

27. BRAVO PE, Cappola TP
    Mental Stress-Induced Myocardial Ischemia: When the Mind Controls the Fate of the Heart.
    JAMA. 2021;326:1803-1804.
    PubMed        
    
    
28. SAMSKY MD, Morrow DA, Proudfoot AG, Hochman JS, et al
    Cardiogenic Shock After Acute Myocardial Infarction: A Review.
    JAMA. 2021;326:1840-1850.
    PubMed         Abstract available
    
    
29. VACCARINO V, Almuwaqqat Z, Kim JH, Hammadah M, et al
    Association of Mental Stress-Induced Myocardial Ischemia With Cardiovascular Events in Patients With Coronary Heart Disease.
    JAMA. 2021;326:1818-1828.
    PubMed         Abstract available
    
    

    
    Lancet

30. KANG J, Koo BK, Park KW, Shin ES, et al
    Aspirin versus clopidogrel after percutaneous coronary intervention - Authors' reply.
    Lancet. 2021;398:1685-1686.
    PubMed        
    
    
31. PAREEK M, Byrne C
    Aspirin versus clopidogrel after percutaneous coronary intervention.
    Lancet. 2021;398:1685.
    PubMed        
    
    
32. XU B, Tu S, Song L, Jin Z, et al
    Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02248.
    PubMed         Abstract available
    
    
33. BYRNE RA, McGovern L
    Angiography-derived quantitative flow ratio guidance of coronary intervention: measure twice, cut once.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02397.
    PubMed        
    
    

    
    N Engl J Med

34. PFEFFER MA, Claggett B, Lewis EF, Granger CB, et al
    Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.
    N Engl J Med. 2021;385:1845-1855.
    PubMed         Abstract available
    
    

    
    PLoS Med

35. HOU Y, Zhou Y, Hussain M, Budd GT, et al
    Cardiac risk stratification in cancer patients: A longitudinal patient-patient network analysis.
    PLoS Med. 2021;18:e1003736.
    PubMed         Abstract available
    
    

    
    PLoS One

36. ROCHA JA, Cardoso JC, Freitas A, Allison TG, et al
    Time-trends and predictors of interhospital transfers and 30-day rehospitalizations after acute coronary syndrome from 2000-2015.
    PLoS One. 2021;16:e0255134.
    PubMed         Abstract available
    
    
37. NOHARA S, Yamamoto M, Yasukawa H, Nagata T, et al
    SOCS3 deficiency in cardiomyocytes elevates sensitivity of ischemic preconditioning that synergistically ameliorates myocardial ischemia reperfusion injury.
    PLoS One. 2021;16:e0254712.
    PubMed         Abstract available
    
    
38. LIU HM, Zheng JP, Yang D, Liu ZF, et al
    Recessive/dominant model: Alternative choice in case-control-based genome-wide association studies.
    PLoS One. 2021;16:e0254947.
    PubMed         Abstract available
    
    
39. MALIK J, Yousaf H, Abbasi W, Hameed N, et al
    Incidence, predictors, and outcomes of DAPT non-compliance in planned vs. ad hoc PCI in chronic coronary syndrome.
    PLoS One. 2021;16:e0254941.
    PubMed         Abstract available
    
    
40. PALMER BR, Paterson MA, Frampton CM, Pilbrow AP, et al
    Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes.
    PLoS One. 2021;16:e0254206.
    PubMed         Abstract available
    
    
41. SKALS R, Krogager ML, Appel EVR, Schnurr TM, et al
    Insulin resistance genetic risk score and burden of coronary artery disease in patients referred for coronary angiography.
    PLoS One. 2021;16:e0252855.
    PubMed         Abstract available
    
    
42. FOKOUA-MAXIME CD, Lontchi-Yimagou E, Cheuffa-Karel TE, Tchato-Yann TL, et al
    Prevalence of asymptomatic or "silent" myocardial ischemia in diabetic patients: Protocol for a systematic review and meta-analysis.
    PLoS One. 2021;16:e0252511.
    PubMed         Abstract available
    
    
43. KIDO K, Ghaffar YA, Lee JC, Bianco C, et al
    Meta-analysis comparing direct oral anticoagulants versus vitamin K antagonists in patients with left ventricular thrombus.
    PLoS One. 2021;16:e0252549.
    PubMed         Abstract available
    
    
44. HUANG Y, Mu R, Wen D, Grimsby JS, et al
    Differences in levels of phosphatidylinositols in healthy and stable Coronary Artery Disease subjects revealed by HILIC-MRM method with SERRF normalization.
    PLoS One. 2021;16:e0252426.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: